Galectin Therapeutics (GALT) Amortizatization of Intangibles (2019 - 2024)
Galectin Therapeutics (GALT) recorded quarterly Amortizatization of Intangibles of $10000.0 in Q4 2024, up 11.11% quarter-over-quarter from $9000.0 in Q3 2024, and up 11.11% on a YoY basis from $9000.0 in Q1 2024.
Galectin Therapeutics (GALT) Amortizatization of Intangibles (2019 - 2024) Analysis & Trends
Galectin Therapeutics' Amortizatization of Intangibles history runs 6 years deep, the most recent figure standing at $10000.0 for Q4 2024.
- In Q4 2024, Amortizatization of Intangibles rose 11.11% year-over-year to $10000.0; the TTM figure through Dec 2024 stood at $37000.0 (up 12.12% YoY), while the FY2025 annual figure was $53000.0, up 43.24% from the prior year.
- Amortizatization of Intangibles was $10000.0 for Q4 2024 at Galectin Therapeutics, up from $9000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $32000.0 in Q1 2023 to a low of -$16000.0 in Q2 2023.
- Historically, Amortizatization of Intangibles has averaged $8950.0 across 5 years, with a median of $9000.0 in 2020.
- Biggest YoY gain for Amortizatization of Intangibles was 220.0% in 2023; the steepest drop was 328.57% in 2023.
- A 5-year view of Amortizatization of Intangibles shows it stood at $9000.0 in 2020, then grew by 22.22% to $11000.0 in 2021, then slipped by 27.27% to $8000.0 in 2022, then rose by 12.5% to $9000.0 in 2023, then gained by 11.11% to $10000.0 in 2024.
- The last three Amortizatization of Intangibles figures came in at $10000.0 (Q4 2024), $9000.0 (Q3 2024), and $9000.0 (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Galectin Therapeutics | 185.83 Mn | 171.73 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 10,000.00 |
| Dec 31, 2024 | 10,000.00 |
| Sep 30, 2024 | 9,000.00 |
| Sep 30, 2024 | 9,000.00 |
| Jun 30, 2024 | 9,000.00 |
| Jun 30, 2024 | 9,000.00 |
| Mar 31, 2024 | 9,000.00 |
| Mar 31, 2024 | 9,000.00 |
| Dec 31, 2023 | 9,000.00 |
| Dec 31, 2023 | 9,000.00 |
| Sep 30, 2023 | 8,000.00 |
| Sep 30, 2023 | 8,000.00 |
| Jun 30, 2023 | -16,000.00 |
| Jun 30, 2023 | -16,000.00 |
| Mar 31, 2023 | 32,000.00 |
| Mar 31, 2023 | 32,000.00 |
| Dec 31, 2022 | 8,000.00 |
| Dec 31, 2022 | 8,000.00 |
| Sep 30, 2022 | 7,000.00 |
| Sep 30, 2022 | 7,000.00 |